Susquehanna Fundamental Investments, LLC Bio Xcel Therapeutics, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BTAI
# of Institutions
49Shares Held
8.58MCall Options Held
34.5KPut Options Held
59.4K-
Armistice Capital, LLC New York, NY4.32MShares$7.51 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$766,7910.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$542,8190.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $48.8M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...